MyBlueDotsNewron and Myung In Pharm Announce License Agreement for evenamide in South Korea MyBlueDots5 months ago01 mins MILAN, Italy & MORRISTOWN, New Jersey & SEOUL, Republic of Korea–(BUSINESS WIRE)—- $NWRN #schizophrenia–Newron and Myung In Pharm, South Korea’s leading specialist CNS pharma company, announce license agreement for evenamide in South Korea. Post navigation Previous: Henry Schein Opens Customer Emergency Support Hotline in Response to California FiresNext: What Illinois residents should know, following the first US death from bird virus
‘Master control switch’ protein that heightens neurodegenerative disease offers new treatment target MyBlueDots4 days ago 0
New findings reveal how the heart is organized from the earliest stages of embryonic development MyBlueDots4 days ago 0
Scholastic performance is a key concern for young cancer patients, study finds MyBlueDots4 days ago 0